SEC 13F Intelligence

Altium Capital Management LLC / AMLX

Altium Capital Management LLC’s Amylyx Pharmaceuticals Inc Position

Does Altium Capital Management LLC own Amylyx Pharmaceuticals Inc (AMLX)? Not currently — the last reported position was 119.5K shares worth $2M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2023
Shares
119.5K
% of Portfolio
+1.19%
Quarters Held
6
position exited

Position History AMLX

Reported value by quarter
Q3 ’22: $985,000Q3 ’22Q4 ’22: $5MQ4 ’22Q1 ’23: $5MQ1 ’23Q2 ’23: $4MQ2 ’23Q3 ’23: $10MQ3 ’23Q4 ’23: $2MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023119.5K$2M+1.19%
Q3 2023534.7K$10M+5.11%
Q2 2023185.0K$4M+3.02%
Q1 2023185.0K$5M+3.01%
Q4 2022140.0K$5M+2.63%
Q3 202235.0K$985,000+0.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of AMLX.